WallStreetZenWallStreetZen

How to Buy Citius Pharmaceuticals Stock

Citius Pharmaceuticals Inc

Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy.

Citius Pharmaceuticals stock last closed at $0.77, down 2.92% from the previous day, and has decreased 53.64% in one year. It has underperformed other stocks in the Biotechnology industry by 0.3 percentage points. Citius Pharmaceuticals stock is currently +27.5% from its 52-week low of $0.60, and -55.26% from its 52-week high of $1.71.

There are currently 159.09M shares of CTXR outstanding. The market cap of CTXR is $121.71M. In the last 24 hours, 721,018 CTXR shares were traded.

How to Buy Citius Pharmaceuticals Stock

Wondering how to invest in Citius Pharmaceuticals stock? Here's how.
  1. Figure out where to buy Citius Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you decide where to buy Citius Pharmaceuticals stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Put funds into your brokerage account: Select your method of payment and add your details.
  4. Analyze Citius Pharmaceuticals stock: The Citius Pharmaceuticals ticker symbol is CTXR. Is Citius Pharmaceuticals stock a good investment? Should you buy shares of CTXR? How do CTXR's underlying business fundamentals look? Do top analysts think Citius Pharmaceuticals is a good buy? Why has CTXR's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if CTXR is a good stock to buy).
  5. Place your CTXR buy order: Decide if you will purchase CTXR shares at the current market price or use a limit order to purchase CTXR stock at a particular price.
  6. Get the latest news on your CTXR investment: Create a watchlist to get live updates on your position in Citius Pharmaceuticals stock.

Step 1: Figure out where to buy Citius Pharmaceuticals stock

You need a brokerage account to access the NASDAQ market and buy CTXR shares.

A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our experience, eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro boasts a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to invest in CTXR today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to create a new brokerage account.
  1. Submit your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have filled out your info on our top ranked stock trading app, your next step is to transfer the money for your investment:

Check out the video below if you need help transferring money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Citius Pharmaceuticals stock

After you have chosen the best place to buy Citius Pharmaceuticals stock, it's crucial to research their stock prior to buying, so you actually understand the risk as well as the upside.

Citius Pharmaceuticals stock data

CTXR Price
$0.77
1w %
-20.4%
1y %
-53.64%
5y %
-34.62%
P/E
-2.94x
P/B
1.44x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$39.33M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$121.71M
Next Earnings
May 10, 2024
Next Dividend
N/A

Citius Pharmaceuticals Zen Score

WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CTXR's stock page.

Is CTXR stock overvalued?

You can use many financial metrics, analyses, models, and charts to gauge CTXR's true value.

Using relative valuations measures:

  • CTXR may be undervalued based on its P/B ratio of 1.44x, relative to Biotechnology industry P/B ratio of 5.88x

You can access more valuation analysis on CTXR's stock here.

CTXR Financial Health Overview

Pros:

  • Total CTXR debt is lower than 5 years ago, relative to shareholder equity.
  • CTXR has a low debt to equity ratio of 0.14.
  • There are more short-term assets than short-term liabilities on the CTXR balance sheet.
  • There are more short-term assets than long-term liabilities on the CTXR balance sheet.

Cons:

  • CTXR has cash burn of 30371083. It does not have enough cash and short-term investments to cover this.
  • CTXR has $20.38M in cash and short term investments. This is not enough to cover its annual cash burn of $30.37M.

Do analysts think it's a good time to buy CTXR stock

Out of 1 sell side analysts who give forecasts on CTXR, the consensus analyst rating on Citius Pharmaceuticals is a Buy

It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Citius Pharmaceuticals stock forecast page.

CTXR Technical Indicators

SMA10
0.9
SMA20
0.86
SMA50
0.78
SMA100
0.77
SMA200
0.82
MACD
0.02
MACD Signal
0.04
MACD Histogram
-0.02
RSI
42.59
Stochastic %K
25.77
Stochastic %D
32.58
StochRSI %K
0
StochRSI %D
1.09

Are CTXR executives and large shareholders buying or selling the stock?

In the past year, executives and large shareholders at CTXR have not bought or sold any shares.

Get more info about who owns CTXR stock here.

Can I rely on CTXR as an income stream?

No, Citius Pharmaceuticals doesn't provide an income stream by paying out dividends.

What do other investors have to say about CTXR?

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other traders have to say.

Step 5: Place your CTXR buy order

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact price limit, place a limit order.

Click the Open Trade button and your broker will execute the order.

If you want additional assistance investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get the latest news on your CTXR investment

Now that you own some CTXR stock, you'll want to keep up with your new investment.

Make a watchlist to track the most important metrics related to your CTXR stock.

CTXR Feed

How to Buy Stock in Citius Pharmaceuticals

To reiterate, here are the 6 steps for buying Citius Pharmaceuticals stock:

  1. Figure out where to buy Citius Pharmaceuticals stock
  2. Sign up for a brokerage account
  3. Put funds into your brokerage account
  4. Analyze Citius Pharmaceuticals stock
  5. Place your CTXR buy order
  6. Get the latest news on your CTXR investment

If you are looking for a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep tabs on your new investment in Citius Pharmaceuticals, create a watchlist today.

NASDAQ: CTXR
$0.77-0.02 (-2.92%)
Updated Apr 15, 2024
Open eToro Account
NASDAQ: CTXR
$0.77-0.02 (-2.92%)
Updated Apr 15, 2024
Open eToro Account

FAQ

How much does it cost to buy one Citius Pharmaceuticals share?

As of Apr 15, 2024, it costs $0.77 to buy one share of Citius Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.38, you can buy 0.5 shares of CTXR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Citius Pharmaceuticals stock?

According to 1 Wall Street analysts who monitor Citius Pharmaceuticals, their consensus recommendation is to buy Citius Pharmaceuticals stock.

What is the best way to buy Citius Pharmaceuticals stock?

One way to place an order for Citius Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.